Prevalence, virulence factors and antifungal susceptibility of oral isolates of Candida albicans from patients with cystic fibrosis in Mexico Ana L. Ríos-López; María Fernanda Garza-Velásquez; Gloria M. González; Miguel A. Becerril-García; Orlando Flores-Maldonado;

From 2012 ESCMID to global 2025 ECMM/ISHAM/ASM Candida guidelines: What are the key differences & practical implications? Cornelia Lass-Flörl;

In vitro activity of juglone (5-hydroxy-1,4-naphthoquinone) against both fluconazole-resistant and susceptible Candida isolates Afsane Vaezi; Masoud Moghadaszadeh; Elahe Nasri; Shima Gharibi; Kambiz Diba; Adam Matkowski; Hamed Fakhim;